Page 391 - Textbook of Pathology, 6th Edition
P. 391

375
             TABLE 14.12: Contrasting Features of AML and ALL.
              Feature              AML                              ALL
           1. Common age           Adults between 15-40 years; com-  Children under 15 years; comprise 80% of childhood
                                   prise 20% of childhood leukaemias  leukaemias
           2. Physical findings    Splenomegaly +                   Splenomegaly ++
                                   Hepatomegaly +                   Hepatomegaly ++
                                   Lymphadenopathy +                Lymphadenopathy ++
                                   Bony tenderness +                Bony tenderness +
                                   Gum hypertrophy +                CNS involvement +
           3. Laboratory findings  Low-to-high TLC; predominance of  Low-to-high TLC, predominance of lymphoblasts in blood
                                   myeloblasts and promyelocytes in  and bone marrow; thrombocytopenia moderate to severe.
                                   blood and bone marrow; throm-
                                   bocytopenia moderate to severe.
           4. Diagnostic criteria  FAB types M0-M7                  FAB types L1-L3, WHO types Pre B (90%) Pre T (10%)
                                   WHO criteria = >20% blasts       WHO criteria = >20% blasts
           5. Cytochemical stains  Myeloperoxidase +, Sudan black +,  PAS +, acid phosphatase (focal) +
                                   NSE + in M4 and M5, acid phos-                                                     CHAPTER 14
                                   phatase (diffuse) + in M4 and M5
           6. Specific therapy     Cytosine arabinoside,            Vincristine, prednisolone, anthracyclines and
                                   anthracyclines (daunorubicin,    L-asparaginase
                                   adriamycin) and 6-thioguanine
           7. Immunophenotyping    CD13, 33, 41, 42                 Both  B and T cell ALL TdT +ve
                                                                    Pre B: CD19, 20
                                                                    Pre T: CD1, 2, 3, 5, 7
           8. Cytogenetics         M3: t(15;17)                     Pre B: t(9;21)
                                   M4: in(16)
           9. Response to therapy  Remission rate low, duration of  Remission rate high, duration of remission prolonged
                                   remission shorter
           10.Median survival      12-18 months                     Children without CNS prophylaxis 33 months, with CNS
                                                                    prophylaxis 60 months; adults 12-18 months



           B-CELL CLL/SLL (CHRONIC LYMPHOCYTIC                   MORPHOLOGIC FEATURES
           LEUKAEMIA/ SMALL LYMPHOCYTIC LYMPHOMA)
                                                                 The diagnosis of CLL can usually be made on the basis of  Disorders of Leucocytes and Lymphoreticular Tissues
           As the name implies, this subtype may present as leukaemia  physical findings and blood smear examination
           or lymphoma constituting 9% of all lymphoid neoplasms.  (Fig. 14.20):
           As lymphoid leukaemia (CLL), this is the most common form  I. BLOOD PICTURE. The findings of routine blood
           while as SLL it constitutes 7%  of all NHLs. B-cell CLL/SLL  picture are as under:
           occurs more commonly in middle and older age groups (over
           50 years of age) with a male preponderance (male-female  1. Anaemia. Anaemia is usually mild to moderate and
           ratio 2:1).                                           normocytic normochromic in type. Mild reticulocytosis
                                                                 may be present. About 20% cases develop a Coombs’-
                                                                 positive autoimmune haemolytic anaemia.
           Clinical Features
                                                                 2. White blood cells. Typically, there is marked leuco-
           The condition may remain asymptomatic, or may have an  cytosis but less than that seen in CML (50,000-200,000/
           insidious onset and may present with nonspecific clinical  μl). Usually, more than 90% of leucocytes are mature small
           features. Common presenting manifestations are as under:  lymphocytes. Smudge or basket cells (degenerated forms)
           1. Features of  anaemia such as gradually increasing  are present due to damaged nuclei of fragile malignant
           weakness, fatigue and dyspnoea.                       lymphocytes. The absolute neutrophil count is, however,
           2. Enlargement of superficial lymph nodes is a very common  generally within normal range. Granulocytopenia occurs
           finding. The lymph nodes are usually symmetrically    when disease is fairly advanced.
           enlarged, discrete and non-tender.                    3. Platelets. The platelet count is normal or moderately
           3. Splenomegaly and hepatomegaly are usual.           reduced as an autoimmune phenomenon.
           4. Haemorrhagic manifestations are found in case of CLL with  II. BONE MARROW EXAMINATION. The typical
           thrombocytopenia.                                     findings are as under:
           5. Susceptibility to Infections, particularly of respiratory tract,  1. Increased lymphocyte count (25-95%).
           are common in CLL.                                    2. Reduced myeloid precursors.
           6. Less common findings are: mediastinal pressure, tonsillar
           enlargement, disturbed vision, and bone and joint pains.  3. Reduced erythroid precursors.
   386   387   388   389   390   391   392   393   394   395   396